Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Sell
31
BRKR Quote, Financials, Valuation and Earnings
Last price:
$47.12
Seasonality move
:
3.87%
Day range:
$46.30 - $47.37
52-week range:
$44.11 - $94.86
Dividend yield:
0.42%
P/E ratio:
62.03x
P/S ratio:
2.09x
P/B ratio:
4.01x
Volume:
1.6M
Avg. volume:
2M
1-year change:
-48.77%
Market cap:
$7.2B
Revenue:
$3.4B
EPS (TTM):
$0.76
Analysts' Opinion
-
Consensus RatingBruker has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $68.42, Bruker has an estimated upside of 45.13% from its current price of $47.14.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $55.00 representing 100% downside risk from its current price of $47.14.
Fair Value
-
According to the consensus of 12 analysts, Bruker has 45.13% upside to fair value with a price target of $68.42 per share.
BRKR vs. S&P 500
-
Over the past 5 trading days, Bruker has overperformed the S&P 500 by 2.19% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Bruker does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Bruker has grown year-over-year revenues for 17 quarters straight. In the most recent quarter Bruker reported revenues of $979.6M.
Earnings Growth
-
Bruker earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Bruker reported earnings per share of $0.09.
Enterprise value:
9.1B
EV / Invested capital:
2.33x
Price / LTM sales:
2.09x
EV / EBIT:
35.70x
EV / Revenue:
2.70x
PEG ratio (5yr expected):
2.41x
EV / Free cash flow:
66.88x
Price / Operating cash flow:
51.80x
Enterprise value / EBITDA:
20.74x
Gross Profit (TTM):
$1.6B
Return On Assets:
2.13%
Net Income Margin (TTM):
3.36%
Return On Equity:
6.78%
Return On Invested Capital:
3.22%
Operating Margin:
16.03%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $2.5B | $3B | $3.4B | $854.5M | $979.6M | |
| Gross Profit | $1.3B | $1.5B | $1.6B | $430.3M | $493.3M | |
| Operating Income | $462.4M | $489.4M | $380.7M | $139.4M | $157M | |
| EBITDA | $518.7M | $675.5M | $438.6M | $282.6M | $124.6M | |
| Diluted EPS | $1.99 | $2.92 | $0.76 | $1.41 | $0.09 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.9B | $2.5B | $2.1B | $2.2B | $2.1B | |
| Total Assets | $3B | $3.7B | $3.6B | $4.2B | $5.8B | |
| Current Liabilities | $791.9M | $938.5M | $914.3M | $1.2B | $1.3B | |
| Total Liabilities | $2.1B | $2.6B | $2.5B | $2.8B | $4B | |
| Total Equity | $974.3M | $1.1B | $1.1B | $1.4B | $1.8B | |
| Total Debt | $844.5M | $1.3B | $1.2B | $1.3B | $2.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $274.4M | $350.1M | $251.3M | $205.5M | $190M | |
| Cash From Investing | -$251.6M | -$326M | -$1.8B | -$36.8M | -$60.6M | |
| Cash From Financing | -$415.3M | -$193.4M | $1.2B | -$59.9M | -$75M | |
| Free Cash Flow | $145.2M | $243.2M | $136M | $174M | $153.3M | |
BRKR
Sector
Market Cap
$7.2B
$37.4M
Price % of 52-Week High
49.69%
45.61%
Dividend Yield
0.42%
0%
Shareholder Yield
-6.16%
-0.75%
1-Year Price Total Return
-48.77%
-38.36%
Beta (5-Year)
1.184
0.774
Dividend yield:
0.42%
Annualized payout:
$0.20
Payout ratio:
26.7%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$46.52
200-day SMA
Sell
Level
$60.38
Bollinger Bands (100)
Sell
Level
51.06 - 60.38
Chaikin Money Flow
Buy
Level
66.5M
20-day SMA
Sell
Level
$48.24
Relative Strength Index (RSI14)
Sell
Level
41.49
ADX Line
Sell
Level
30.77
Williams %R
Neutral
Level
-52.6562
50-day SMA
Sell
Level
$53.74
MACD (12, 26)
Sell
Level
-2.13
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
60.9M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.8009)
Sell
CA Score
(Annual)
Level (-0.8277)
Buy
Beneish M-Score
(Annual)
Level (-2.2686)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (2.1513)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Stock Forecast FAQ
In the current month, BRKR has received 7 Buy ratings 5 Hold ratings, and 0 Sell ratings. The BRKR average analyst price target in the past 3 months is $68.42.
-
Where Will Bruker Stock Be In 1 Year?
According to analysts, the consensus estimate is that Bruker share price will rise to $68.42 per share over the next 12 months.
-
What Do Analysts Say About Bruker?
Analysts are divided on their view about Bruker share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bruker is a Sell and believe this share price will drop from its current level to $55.00.
-
What Is Bruker's Price Target?
The price target for Bruker over the next 1-year time period is forecast to be $68.42 according to 12 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is BRKR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Bruker is a Buy. 7 of 12 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BRKR?
You can purchase shares of Bruker via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bruker shares.
-
What Is The Bruker Share Price Today?
Bruker was last trading at $47.12 per share. This represents the most recent stock quote for Bruker. Yesterday, Bruker closed at $47.14 per share.
-
How To Buy Bruker Stock Online?
In order to purchase Bruker stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
52
RGC alert for Mar 19
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is down 10.69% over the past day.
Buy
93
ESLT alert for Mar 19
Elbit Systems [ESLT] is up 10.52% over the past day.
